Gurunath, Ravichandra Karra External Entity

Publications

Sort by

Selected publications

  • Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.  The Lancet. Oncology2015 Academic Article GET IT
    Times cited: 197

Other